Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 574 clinical trials
Evaluation of an Early Support Programme in Orthophony

Prospective, interventionnal with minimal risks and constraints, multicentric, non-randomized, open study, to measure the impact of an early support programme in speech and language therapy for vulnerable children (PAPEV-ortho), in children born very prematurely or very hypotrophically, on the incidence of language and communication deficits at the corrected age of …

intrauterine growth retardation
premature birth
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)

Significant advances in molecular nuclear medicine imaging in prostate cancer have been achieved in recent years. In particular, the introduction of prostate-specific membrane antigen (PSMA) -based tracers has significantly influenced diagnostic imaging of prostate. If cancer recurs after surgical removal of the prostate, targeted PSMA PET (positron emission tomography) can …

local therapy
positron emission tomography
prostatectomy
lymphadenectomy
prostate specific antigen
  • 0 views
  • 19 Feb, 2024
  • 1 location
Lutetium-177-PSMA-I&T in Oligo-metastatic Hormone Sensitive Prostate Cancer

  Radioligand therapy (RLT) using Lutetium-177 labelled PSMA is a promising new therapeutic approach to treat metastatic prostate cancer. This tumor-specific treatment is directed against prostate-specific membrane antigen (PSMA), which is overexpressed in prostate cancer cells. In the last few years, several lutetium-177 (177Lu, emitter) labeled PSMA ligands have been …

cabazitaxel
testosterone
platelet count
finasteride
bicalutamide
  • 4 views
  • 19 Feb, 2024
  • 4 locations
A Home-based Physical Activity Programme for Patients With Advanced Interstitial Lung Diseases (iLiFE)

Interstitial lung diseases (ILD) are a highly incapacitating group of chronic respiratory diseases, leading to disabling symptoms and impaired capacity to perform activities of daily living and health-related quality of life (HRQoL). It is known that people with ILD are highly inactive and sedentary, and in a severe stage of …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Validation Study of an Assistive Pulse Data Collection Device

Background: Traditional Chinese Medicine (TCM) relies on pulse diagnosis, a subjective and complex method that is crucial for assessing patients' health status. The COVID-19 pandemic has disrupted healthcare delivery, highlighting the need for remote diagnostic tools. To address this, an Assistive Pulse Data Collection Device (APDC) has been developed to …

Accepts healthy volunteers
  • 0 views
  • 16 May, 2025
  • 1 location
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Purpose of Study The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.

acute respiratory syndrome (sars)
SARS
absolute lymphocyte count
chest x-ray
fraction of inspired oxygen (fio2)
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)

  • To document the real-world effectiveness and safety of treatments.
  • ul>

    • 0 views
    • 23 May, 2025
    • 1 location
    • 0 views
    • 19 Feb, 2024
    • 1 location
    Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

  • To identify patients with higher risk of deep venous thrombosis.
  • ul>

    thrombosis
    covid-19
    deep vein thrombosis
    • 0 views
    • 19 Feb, 2024
    • 1 location
    Mucopolysaccharidosis I (MPS I) Registry

    The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities.

    The objectives of the Registry …

    • 0 views
    • 19 Feb, 2024
    • 136 locations